×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Advanced Enzyme Technologies L | 1788.76 | 739.81 | 1250.24 | 6.61 | 3,871 | 28.3 |
| VIMTA LABS LTD. | 993.13 | 188.94 | 975.64 | 4.21 | 3759 | 61.8 |
| Orchid Pharma Limited | 1888.59 | 181.97 | 1729.29 | 3.59 | 3582 | 42.0 |
Advanced Enzyme Technologies Limited, with Security Code 540025, is a leading player in the Biotechnology industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 82.6 | 85.3 | 96.6 | 91.1 | 92.4 | 86.0 | 77.4 | 100.9 | 87.2 | 125.0 |
| Expenses | 59.3 | 60.6 | 70.0 | 66.6 | 63.2 | 65.0 | 63.9 | 78.8 | 73.0 | 94.5 |
| Operating Profit | 23.3 | 24.8 | 26.6 | 24.5 | 29.2 | 20.9 | 13.5 | 22.1 | 14.2 | 30.5 |
| OPM % | 28.2% | 29.03% | 27.56% | 26.93% | 31.65% | 24.34% | 17.48% | 21.87% | 16.28% | 24.42% |
| Other Income | 2.8 | 51.2 | 0.8 | 3.6 | -15.7 | 53.9 | 1.7 | 1.4 | 4.5 | 53.9 |
| Interest | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 |
| Depreciation | 2.8 | 2.5 | 2.6 | 2.7 | 3.1 | 2.6 | 2.8 | 2.9 | 3.1 | 2.9 |
| Profit before tax | 23.3 | 73.5 | 24.8 | 25.4 | 29.3 | 72.2 | 12.3 | 20.5 | 15.5 | 81.4 |
| Tax % | -24.8% | -8.2% | -25.8% | -24.6% | -69.8% | -7.1% | -25.9% | -26.1% | -28.4% | 9.1% |
| Net Profit | 17.5 | 67.5 | 18.4 | 19.1 | 3.1 | 67.1 | 9.1 | 15.2 | 11.1 | 74.0 |
| EPS in Rs | 1.56 | 6.04 | 1.64 | 1.71 | 0.28 | 5.99 | 0.81 | 1.35 | 0 | 6.61 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 142.1 | 138.7 | 147.3 | 157.8 | 160.9 | 157.8 | 154.5 | 146.1 | 169.1 | 167.2 |
| Expenses | 100.4 | 94.6 | 103.3 | 106.5 | 107.2 | 102.4 | 103.4 | 103.7 | 113.9 | 121.5 |
| Operating Profit | 41.7 | 44.1 | 44.0 | 51.3 | 53.8 | 55.4 | 51.2 | 42.4 | 55.3 | 45.7 |
| OPM % | 29.34% | 31.83% | 29.89% | 32.51% | 33.41% | 35.08% | 33.11% | 29.03% | 32.67% | 27.32% |
| Other Income | 8.5 | 7.0 | 6.7 | 6.1 | 14.4 | -5.6 | 7.0 | 9.6 | 7.7 | 8.7 |
| Interest | 0.6 | 0.6 | 0.6 | 0.8 | 0.7 | 0.8 | 0.9 | 0.9 | 0.9 | 0.8 |
| Depreciation | 9.1 | 8.4 | 8.6 | 8.7 | 8.6 | 9.3 | 8.6 | 8.9 | 9.0 | 10.1 |
| Profit before tax | 40.5 | 46.2 | 41.4 | 47.9 | 58.9 | 54.7 | 48.7 | 42.2 | 53.0 | 43.5 |
| Tax % | -31% | -23.7% | -29% | -26.6% | -27.8% | -24.6% | -28.1% | -20.9% | -26.7% | -38.4% |
| Net Profit | 27.9 | 32.1 | 29.4 | 35.2 | 42.5 | 29.9 | 35.0 | 33.4 | 38.9 | 26.7 |
| EPS in Rs | 2.63 | 2.87 | 2.58 | 3.08 | 3.74 | 2.53 | 3.05 | 2.93 | 3.36 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 7% |
| 3 Years: | 9% |
| TTM: | -4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 12% |
| 3 Years: | 24% |
| TTM: | -17% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 14% |
| 3 Years: | 1% |
| 1 Year: | -22% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 7% |
| 3 Years: | 6% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 0% |
| 3 Years: | 3% |
| TTM: | -9% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 14% |
| 3 Years: | 1% |
| 1 Year: | -22% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|